<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cotecna Life Sciences India Inaugurates New Laboratory in Mumbai</title>
    <link>https://www.taxtmi.com/news?id=32135</link>
    <description>The document announces a new Mumbai laboratory that is FDA-approved and NABL-accredited, offering regulatory-grade analytical testing-including impurity analysis, stability studies, and pharmacopeial testing-to support drug development and manufacturers&#039; compliance. It will operate within a global GMP-aligned network to provide validated methods, quality assurance, and certification-oriented testing enabling regulatory conformity and market access.</description>
    <language>en-us</language>
    <pubDate>Fri, 31 Jan 2025 16:16:04 +0530</pubDate>
    <lastBuildDate>Fri, 31 Jan 2025 16:16:04 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=793943" rel="self" type="application/rss+xml"/>
    <item>
      <title>Cotecna Life Sciences India Inaugurates New Laboratory in Mumbai</title>
      <link>https://www.taxtmi.com/news?id=32135</link>
      <description>The document announces a new Mumbai laboratory that is FDA-approved and NABL-accredited, offering regulatory-grade analytical testing-including impurity analysis, stability studies, and pharmacopeial testing-to support drug development and manufacturers&#039; compliance. It will operate within a global GMP-aligned network to provide validated methods, quality assurance, and certification-oriented testing enabling regulatory conformity and market access.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Fri, 31 Jan 2025 16:16:04 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=32135</guid>
    </item>
  </channel>
</rss>